HURA Stock — TuHURA Biosciences, Inc.

Up next

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed May 15, 2026

Equibles Rating

blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Sell Momentum Strong Sentiment Neutral Fundamentals Strong Quant / Vol Very High

Market backdrop VIX 18.2 · elevated Equity put/call 0.71

Technical

price trend

Sell

50 / 200-day cross No cross

Price vs 200-day avg +15%

above

Price vs 50-day avg −8%

below

RSI (14) 43

neutral

MACD trend Negative

52-week position 49%

mid-range

Momentum

relative strength

Strong

1-month return −7%

trailing

6-month return +356%

trailing

YTD return +181%

this year

Relative strength +349%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $2 › 200d $2 — 50d above 200d

Institutional flow Distributing

19 of 88 funds reported for Jun 30 · net -20.2K sh shares · +3 new

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

10.44% of float · ▼ -4.9% MoM · 15.5 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

88 holders — near 1-yr high, broad support

Squeeze score 69

elevated · 0–100

Fundamentals

Strong

EPS growth +48%

Y/Y

Free cash flow $-27.7M

Balance sheet $3.6M

net cash

Quant / Vol

risk profile

Very High

Volatility 135%

annualized · 1-yr

Max drawdown −86%

past year

ATR 7.5%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell

2 · 3 · 1

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+15% Bullish

Price vs 50-day avg

−8% Bearish

RSI (14)

43 Neutral

MACD trend

Negative Bearish

52-week position

49% Neutral

Market signals — smart money & positioning

Bullish · 2 of 6

Trend (MA cross) No cross

50d $2 › 200d $2 — 50d above 200d

Institutional flow Distributing

19 of 88 funds reported for Jun 30 · net -20.2K sh shares · +3 new

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

10.44% of float · ▼ -4.9% MoM · 15.5 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

88 holders — near 1-yr high, broad support

Price context

position in its 52-week range

52-wk low $0 Now $2 · 49% 52-wk high $4

vs 200-day avg +15% vs 50-day avg -8%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings

Metric	Latest	Period	YoY
Total common shares outstanding	63.6M	First Quarter 2026	—

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Biotechnology — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
HURA TuHURA Biosciences, Inc./NV this stock	$135.64M	+181.4%	—	—	10.4%
ONC BeOne Medicines Ltd.	$472.90B	+8.8%	+22179.2%	962.4	0.1%
VRTX Vertex Pharmaceuticals Inc / Ma	$124.46B	+8.2%	+46.2%	29.1	2.0%
REGN Regeneron Pharmaceuticals, Inc.	$72.88B	-9.8%	+20.8%	17.0	3.3%
ARGX Argenx SE	$54.57B	+3.7%	—	—	2.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Reducing

Holders

89

% held: 14.4%
Reported: 19 of 88
Top holder: BlackRock, Inc.

Held Float

View

Held by Funds

Fund positions

64

View

Short & Settlement

Short Interest Falling

Shares short

6.6M

Days to cover: 15.5d
Change: -344.7K sh

View

Short Volume

Short vol %

36%

As of: Jul 29, 2026

Short Total

View

Fails to Deliver

FTD shares

45.6K

Value: $104.3K
As of: Jun 30, 2026

View

Off-Exchange

Off-exchange %

47.7%

Week of: May 4, 2026

Off-exch Lit

View

Smart Money

Congressional Trades Buy

Member

Laurel Lee

Amount: $50.0K–$100.0K
Traded: Jul 13, 2025

View

Financials

Revenue (FY)

$0

Net income (FY): $-31.0M
EPS diluted: $-0.63

View

Filings

SEC Filings

Latest

DEF 14A

Filed: Jul 9, 2026
This year: 13

View

Exempt Offerings

Offering

$3.0M

Filed: Nov 10, 2025

View

Earnings & Events

Earnings Calls Upcoming

Next call

Aug 12, 2026

View

Investor Relations

Upcoming events

2

View

	5D	20D	120D	MTD	YTD
HURA	-3.6%	-7.0%	+356.1%	-9.0%	+181.4%
SPY	-1.0%	0.0%	+7.4%	-0.8%	+8.6%
vs SPY	-2.6%	-7.0%	+348.7%	-8.2%	+172.7%

HURA · TuHURA Biosciences, Inc./NV

Price & Indicators

Up next

Equibles Rating

Technicals

Key metrics

Versus peers

At a glance

Performance